EastGate Biotech Corp. Enters Into a 3-way International Distribution Agreement With Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc.
17. Mai 2021 09:30 ET
|
EastGate Biotech Corp.
The terms of the distribution agreement allows ImmunoJuvenate to market an entire product catalogue under Private label in the United States, Canada and international markets WEST CALDWELL, NJ...
EastGate Biotech Corp. Enters into a Licensing and Distribution Agreement for Glucora, One of Its Nutraceutical Products for the US, Canadian, Central and South American Markets
08. März 2021 09:30 ET
|
EastGate Biotech Corp.
The Licensing Fee of $3 Million USD to be Paid in a Combination of Cash and Sales-Driven Funding WEST CALDWELL, NJ and TORONTO, ON, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – EastGate...
EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19
18. Februar 2020 09:30 ET
|
EastGate Biotech Corp.
Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnesses WEST CALDWELL, NJ and TORONTO, ON, Feb. 18, 2020 (GLOBE...
EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus
30. Januar 2020 09:00 ET
|
EastGate Biotech Corp.
WEST CALDWELL, NJ and TORONTO, ON, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company, that focuses on innovative technological...
EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights
30. Dezember 2019 09:00 ET
|
EastGate Biotech Corp.
WEST CALDWELL, NJ and TORONTO, ON, Dec. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological...
EastGate Biotech Expands Pipeline to Alzheimer’s Disease Using its Alternative Insulin Delivery Platform
14. November 2019 09:30 ET
|
EastGate Biotech Corp.
WEST CALDWELL, NJ and TORONTO, ON, Nov. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological...
EastGate Biotech Announces Expansion and Restructuring of Joint Venture with its Partner in Pakistan
09. Oktober 2019 09:15 ET
|
EastGate Biotech Corp.
Key products to be tested, registered and marketed include Insugin for diabetes application, alternative insulin for Alzheimer’s application, and Blood Plasma Derived Products, Human Serum Albumin 20%...
EastGate Biotech Receives Regulatory Approval to Initiate a Phase III 90-day Clinical Trial on Insugin, Its Liquid Insulin Mouth Rinse Solution
25. September 2019 09:00 ET
|
EastGate Biotech Corp.
The Marketing Application Approval in Pakistan will follow subject to completion of the Phase III clinical study that will include up to 200 Type 2 patients WEST CALDWELL, NJ and TORONTO, ON, Sept. ...
EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer
04. September 2019 09:15 ET
|
EastGate Biotech Corp.
WEST CALDWELL, NJ and TORONTO, ON, Sept. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological...
EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin
26. Juni 2019 09:15 ET
|
EastGate Biotech Corp.
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan WEST CALDWELL, NJ and TORONTO, ON, June 26, 2019 (GLOBE NEWSWIRE) -- via...